Ott Pharmacotherapy of Bipolar Disorder Flashcards
Why is bipolar disorder often misdiagnosed?
Depression is the mood pole that is experienced most often in bipolar disorder, often people are diagnosed with depression instead
Comorbidities associated with bipolar disorder
-Alcohol and substance use common (50-60%)
-Anxiety disorders are common comorbidities and can significantly impact remission of mood episodes if left untreated or inadequately treated
How is bipolar 1 disorder defined?
1 or more manic episodes
How is bipolar 2 disorder defined?
Hypomanic episodes generally lasting 4 days or more
Lithium clinical pearls
-Associated with decrease in suicidality
-Narrow therapeutic index medication
-Some differences in lithium content, but use 1:1 conversion between liquid and tablet
Lithium dosing for acute treatment
0.9-1.2 mEq/L
Lithium dosing for maintenance therapy
0.6-0.9 mEq/L
Lithium dosing that leads to toxicity
1.5 - >30 mEq/L
How is lithium dosing monitored?
Draw trough serum concentration 72 hours after dose initiation, 12 hours after last dose
Symptoms of lithium toxicity
-GI upset
-Ataxia
-Coarse hand tremor
-Altered mental status
-Seizure
-Lethargy
-Confusion
-Agitation
Lithium side effects
-Fine hand tremor
-Hypothyroidism
-Polyuria
-Polydipsia
-Acne
-Dry mouth
-Weight gain
-ECG changes
Teratogenic effects of lithium
-Cardiac structure abnormality (Ebstein’s anomaly)
-Avoid in first trimester - use with caution in second and third trimester
Lithium monitoring parameters
-SCr, BUN (almost entirely renally excreted)
-Urine specific gravity
-Na, K, Ca
-ECG (especially if age is over 40 or other risk factors)
-Thyroid function - TSH, T4
-Parathyroid hormone
-CBC with differential
-Weight
-Pregnancy test
Lithium drug interactions
-Decreased lithium renal clearance (increase in lithium levels) - ACEi, ARBs, thiazide diuretics, NSAIDs, dehydration
-Increased Li renal clearance (decreased Li levels) - caffeine, osmotic diuretics, +/- loop diuretics
-Increased Li excretion (decreased Li levels) - sodium bicarbonate, high Na intake
-Toxicity related to Na depletion - thiazide diuretics
Valproate clinical pearls
-Extended release form is ~10-15% less bioavailable than delayed release dosage form
-1:1 conversion, expect lower serum concentration with ER dosage form - usually not clinically significant
-Valproic acid syrup and capsule sprinkle form have a higher risk for GI ulcerations (usually esophageal)
-serum levels 80-125 mcg/ml associated with most efficacy in mania, obtain level at least 96 hours after first dose or dose increase